drugset / Trial / NCT03014778

Efficacy of Two Vaginal Solutions in Preoperative Use

NCT03014778

Phase 4 Unknown 70 enrolled HaEmek Medical Center, Israel
RandomizedParallel-groupSingle-blindOther

Summary

This study is necessary in order to provide proof the effectiveness of Chlorhexidine gluconate and its safety.

Timeline

Start
2017-01-01
Primary completion
2018-12-31
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 0.05 % Other
Comparator Povidone-Iodine Other / unclassified 10 % Other

Indications

No indication recorded.